New drug aims to help people lose fat while keeping muscle
NCT ID NCT06445075
Summary
This study tested whether adding an experimental drug called apitegromab to a standard weight loss medication (tirzepatide) could help overweight and obese adults lose weight more effectively. Researchers wanted to see if the combination could help people lose fat while preserving their muscle mass. The 24-week trial involved 102 adults without diabetes who were randomly assigned to receive either apitegromab or a placebo alongside their weight loss medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Translational Research Institute
Orlando, Florida, 32804, United States
-
Alliance for Multispecialty Research, LLC
Norman, Oklahoma, 73069, United States
-
Apex Mobile Clinical Research
Bellaire, Texas, 77401, United States
-
Clinical Trials of Texas, LLC dba Flourish Research
San Antonio, Texas, 78229, United States
-
Great Lakes Clinical Trials, LLC d/b/a Flourish Research
Chicago, Illinois, 60640, United States
-
ProSciento CRU
Chula Vista, California, 91911, United States
-
Tandem Clinical Research GI, LLC
Marrero, Louisiana, 70072, United States
Conditions
Explore the condition pages connected to this study.